Hepatocellular carcinoma (HCC) is a cancer which occurs in liver and severity of this cancer
makes it the sixth most prevalent cancer and second leading cause of death among all …

Hepatocellular carcinoma (HCC) is a common malignancy and now the second commonest
global cause of cancer death. HCC tumorigenesis is relatively silent and patients experience …

The clinical value of Serum alpha-fetoprotein (AFP) to detect early hepatocellular carcinoma
(HCC) has been questioned due to its low sensitivity and specificity found in recent years …

Hepatocellular carcinoma (HCC) is one of the most recurrent and lethal cancers worldwide.
The low survival rate of this particular strain of carcinoma is largely due to the late stages at …

Purpose Early detection of hepatocellular carcinoma (HCC) is essential for improved
prognosis and long-term survival. To date, screening for HCC depends on serological …

Primary liver cancer is the sixth most common cancer in the world and the third cause of
cancer-related death. Hepatocellular carcinoma (HCC) represents more than 90% of …

Background Hepatocellular carcinoma (HCC) occurs mostly in people with chronic liver
disease and ranks sixth in terms of global instances of cancer, and fourth in terms of cancer …

Results Serum tumor markers, such as alpha-fetoprotein (AFP) and des-gammacarboxy
prothrombin (DCP) are commonly used for the surveillance, but their roles have been …

Background: Hepatocellular carcinoma (HCC) is a common and dangerous malignancy in
many parts of the world, and especially in Egypt. Early diagnosis is the most important step …

Abstract Background & Aims Squamous cell carcinoma antigen (SCCA) and its immune
complex (SCCA‐IgM) have been proposed for use in the screening of hepatocellular …